Zobrazeno 1 - 10
of 38
pro vyhledávání: '"W. H. J. P. Linssen"'
Autor:
W. H. J. P. Linssen, Ludo van der Pol, Nicol C. Voermans, René de Coo, Annemarie Fock, Ieke B. Ginjaar, Jessica E. Hoogendijk, Marianne de Visser, Karin G. Faber, Jan B. M. Kuks, Aad Verrips, Anneke J. van der Kooi, Erik H. Niks, Esther Brusse, Dineke Westra, Leroy ten Dam, Chiara S. M. Straathof, W. S. Frankhuizen
Publikováno v:
Clinical Genetics, 96, 126-133
Clinical Genetics, 96(2), 126-133. Wiley
Clinical Genetics, 96, 2, pp. 126-133
Clinical Genetics, 96(2), 126-133. Wiley-Blackwell Publishing Ltd
Clinical genetics, 96(2), 126-133. Wiley-Blackwell
Clinical Genetics, 96(2), 126-133
Clinical Genetics, 96(2), 126-133. Wiley
Clinical Genetics, 96, 2, pp. 126-133
Clinical Genetics, 96(2), 126-133. Wiley-Blackwell Publishing Ltd
Clinical genetics, 96(2), 126-133. Wiley-Blackwell
Clinical Genetics, 96(2), 126-133
In this retrospective study, we conducted a clinico-genetic analysis of patients with autosomal recessive limb-girdle muscular dystrophy (LGMD) and Miyoshi muscular dystrophy (MMD). Patients were identified at the tertiary referral centre for DNA dia
Autor:
C. G. Faber, Jan B. M. Kuks, W. S. Frankhuizen, H.B. Ginjaar, A. J. van der Kooi, W. H. J. P. Linssen, Chiara S. M. Straathof, M. de Visser, L. ten Dam, Dineke Westra, Johanna M. Fock, W.L. van der Pol, Nicol C. Voermans, Esther Brusse, I.F.M. de Coo, Jessica E. Hoogendijk, Aad Verrips, Erik H. Niks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a68271c42a6fbaffe7d038370bc7ae3
https://doi.org/10.1111/cge.13544/v2/response1
https://doi.org/10.1111/cge.13544/v2/response1
Autor:
Anneke J. van der Kooi, Marianne de Visser, Leroy ten Dam, W. H. J. P. Linssen, Fleur Rövekamp
Publikováno v:
Neuromuscular disorders, 24(12), 1097-1102. Elsevier Limited
In this retrospective cross-sectional study clinical and muscle imaging data of patients with Miyoshi distal myopathy phenotype (MMD1 and MMD3) and limb girdle muscular dystrophy 2L (LGMD2L) were described. MMD1 and MMD3 are genetically heterogenous
Autor:
W. H. J. P. Linssen, John H. J. Wokke, M. de Visser, Nicolas Lévy, W G de Voogt, H.B. Ginjaar, Martin Krahn, Rafaëlle Bernard
Publikováno v:
European Journal of Neurology, 20(6), 968-974
European journal of neurology, 20(6), 968-974. Wiley-Blackwell
European journal of neurology, 20(6), 968-974. Wiley-Blackwell
To describe the long-term follow-up of a cohort of 22 patients with the Miyoshi phenotype of distal muscular dystrophy (MMD). A long-term clinical follow-up study was conducted. Patients were genotyped for dysferlin (MMD1) or anoctamin 5 (MMD3) mutat
Autor:
R.J. de Haan, Joris J. Berkhout, M. de Visser, L. H. van den Berg, J. C. van Swieten, Joost Raaphorst, Janne M. Papma, Emma Beeldman, Helenius J. Schelhaas, Janneke G. Weikamp, Hepke F Grupstra, Yolande A.L. Pijnenburg, Ben Schmand, W. H. J. P. Linssen
Publikováno v:
Neurology, 79(13), 1377-1383. Lippincott Williams & Wilkins
Neurology, 79(13), 1377-1383. Lippincott Williams and Wilkins
Raaphorst, J, Beeldman, E, Schmand, B, Berkhout, J, Linssen, W H J P, Van den Berg, L H, Pijnenburg, Y A L, Grupstra, H F, Weikamp, J G, Schelhaas, H J, Papma, J M, van Swieten, J C, de Visser, M & de Haan, R J 2012, ' The ALS-FTD-Q: A new screening tool for behavioral disturbances in ALS ', Neurology, vol. 79, no. 13, pp. 1377-1383 . https://doi.org/10.1212/WNL.0b013e31826c1aa1
Neurology, 79(13), 1377-1383. American Academy of Neurology
Neurology, 79, 13, pp. 1377-83
Neurology, 79, 1377-83
Neurology, 79(13), 1377-1383. Lippincott Williams and Wilkins
Raaphorst, J, Beeldman, E, Schmand, B, Berkhout, J, Linssen, W H J P, Van den Berg, L H, Pijnenburg, Y A L, Grupstra, H F, Weikamp, J G, Schelhaas, H J, Papma, J M, van Swieten, J C, de Visser, M & de Haan, R J 2012, ' The ALS-FTD-Q: A new screening tool for behavioral disturbances in ALS ', Neurology, vol. 79, no. 13, pp. 1377-1383 . https://doi.org/10.1212/WNL.0b013e31826c1aa1
Neurology, 79(13), 1377-1383. American Academy of Neurology
Neurology, 79, 13, pp. 1377-83
Neurology, 79, 1377-83
Objective: The assessment of behavioral disturbances in amyotrophic lateral sclerosis (ALS) is important because of the overlap with the behavioral variant of frontotemporal dementia (ALS-bvFTD). Motor symptoms and dysarthria are not taken into accou
Autor:
W. H. J. P. Linssen, Rumaisa Bashir, Sari Kiuru-Enari, Marianne de Visser, Ibrahim Mahjneh, Antti Lamminen
Publikováno v:
Neuromuscular disorders, 22(2), S130-S136. Elsevier Limited
Anoctaminopathy is a new muscular dystrophy caused by mutations in the ANO5 gene. ANO5 mutations cause distal and proximal phenotypes. We report here a follow-up muscle MRI study on five patients affected by distal form of anoctaminopathy. T1 weighte
Autor:
Marie-José van Tol, Marianne de Visser, W. H. J. P. Linssen, Anneke J. van der Kooi, Ben Schmand, Leonard H. van den Berg, Rob J. de Haan, Joost Raaphorst
Publikováno v:
Journal of Neurology, Neurosurgery and Psychiatry, 82(2), 170-175. BMJ Publishing Group
Journal of neurology, neurosurgery, and psychiatry, 82(2), 170-175. BMJ Publishing Group
Journal of Neurology, Neurosurgery and Psychiatry, 82(2), 170-175
Journal of neurology, neurosurgery, and psychiatry, 82(2), 170-175. BMJ Publishing Group
Journal of Neurology, Neurosurgery and Psychiatry, 82(2), 170-175
AimIn contrast with findings in amyotrophic lateral sclerosis (ALS), cognitive impairments have as yet not been shown in the lower motor neuron variant of motor neuron disease, progressive spinal muscular atrophy (PMA). The objective of this study wa
Publikováno v:
Tijdschrift voor kindergeneeskunde. 78:131-137
Publikováno v:
Amyotrophic Lateral Sclerosis, 11(1-2), 27-37. Informa Healthcare
We aimed to clarify the profile of cognitive impairment in ALS, by meta-analysis of published studies. Criteria for inclusion were: ALS diagnosed according to El Escorial criteria; control group matched for age and education; correction for bias due
Publikováno v:
Headache: The Journal of Head and Face Pain. 43:395-399
Objective.—To evaluate the effectiveness of sumatriptan 20 mg via nasal spray and 100-mg tablets in treating migrainous headache in patients without a concomitant migraine diagnosis. Methods.—We prospectively investigated the efficacy of sumatrip